alzheimer-s

Documents about alzheimer-s

• The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin#312253Muğla Sıtkı Koçman University Institutional Repository
• Detecting Alzheimer’s Disease through Chinese Speech: A Contrast of Manual and Automatic Linguistic Feature Extraction#368857OSF
• Thalamic nuclei insights into Alzheimer's disease#314144bioRxiv / medRxiv
• Quantitation of Spatial Proteoforms in Alzheimer's Disease#422359bioRxiv / medRxiv
• Entre el silenci dels records: recerca d’una memòria perduda. Nous enfocaments terapèutics en la malaltia de l’Alzheimer#185002Dipòsit Digital de la Universitat de Barcelona
• The Role of Verbal Memory in Masking Symptoms of Alzheimer's Disease#13909bioRxiv / medRxiv
• Restoring Theta–Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.#30688NCBI PubMed Central
• The YTHDF proteins shape the brain gene signatures of Alzheimer's disease#290724bioRxiv / medRxiv
• Greater Amyloid Burden in Cognitive Networks in Preclinical Alzheimer's Disease#310915bioRxiv / medRxiv
• Baseline FDG-PET Brain hypometabolism as a predictive biomarker of cognitive decline and Alzheimer's disease risk#182055Europe PMC
• Comparative Analysis of Deep Learning Techniques in Alzheimer's Disease Diagnosis: Trends, Challenges, and Future Directions#205465Europe PMC
• Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease#212948Europe PMC
• The impact of the interaction between SIRT1 and lifestyle factors on Alzheimer’s disease risk and related phenotypes#223394Research Online
• Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study#273347Europe PMC
• Indole Metabolites as Modulators of Human Cholinesterases: A Kinetic and Molecular Docking Study with Comparison to Alzheimer's Drugs#315267Muğla Sıtkı Koçman University Institutional Repository
• Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: an analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)#319784bioRxiv / medRxiv
• Multimodal Machine Learning for Alzheimer's Disease Classification Using ADNI Biomarker Fusion#396647ODU Digital Commons
• Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics#161197HAL (France)
• Studying the interaction between Polyoxometalates and Amyloid peptides in the context of Alzheimer’s disease#195713HAL (France)
• Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation#5503Europe PMC
• Probing the Roles of Connexin 43 Hemichannels in a Mouse Model of Alzheimer's Disease#176225DigitalCommons@USU
• Physical Exercise and Mechanism Related to Alzheimer’s Disease: Is Gut–Brain Axis Involved?#197444Repositorio UNAB
• Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model#231289Europe PMC
• Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease#384127CiNii
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#162235PubMed
• Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants.#251014NCBI PubMed Central
• Expression of GPR34 in microglia remains stable in human Alzheimer's disease.#284899NCBI PubMed Central
• Mapping individual molecular connectomes in Alzheimer's disease.#123051NCBI PubMed Central
• Immune receptor LAG3 regulates microglia function during Alzheimer’s disease#217724Europe PMC
• Tau-Connectome Predictive Modeling and Subtyping in Preclinical Alzheimer's Disease#256630EliScholar
• Stress, stress systems, and Alzheimer's disease.#265469NCBI PubMed Central
• Exploring longitudinal relationships among Alzheimer's disease biomarkers.#420892NCBI PubMed Central
• Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study#8270HAL (France)
• Life satisfaction and risk of dementia over 18 years: an analysis of the National Alzheimer's Coordinating Center dataset#257567HAL (France)
• Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells#274375HAL (France)
• Table 1_Dynamic changes of gut microbiota during progression of three Alzheimer’s disease mice models.xls#300637Figshare
• Identifying the determinants of hospital readmission in dementia patients – A retrospective cohort study using electronic healthcare records in England#372107PLOS
• The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis#276425Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.#480974NCBI PubMed Central
• “Las formas de olvido y las formas de memoria: los múltiples sentidos en una dinámica familiar que gira en torno al Alzheimer”,#188251Repositorio Institucional Javeriano
• <i>Blautia coccoides</i>-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signaling#5183Europe PMC
• Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance#167578Digital Commons @ University of Georgia School of Law
• Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease using Blood-Based Biomarkers and Amyloid-Beta PET: A Survival Analysis Approach#235048Harvard DASH
• The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review#253598Europe PMC
• Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways#320931SWU eJournals System
• System changes to empower primary care in Alzheimer's disease detection and care.#143063NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing#143862bioRxiv / medRxiv
• Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true?#154483NCBI PubMed Central
• Investigating causal associations among inflammatory proteins, blood metabolites, and Alzheimer's disease risk.#322992NCBI PubMed Central
• CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760IRIS